Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Base de datos
País/Región como asunto
Tipo del documento
Asunto de la revista
Intervalo de año de publicación
1.
J Vasc Access ; 13(4): 421-5, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22505280

RESUMEN

PURPOSE: Peripherally Inserted Central Catheters (PICCs) are increasingly being used to provide short to medium-term central venous access. The current study was designed to test the hypothesis that PICC valve technology does not influence PICC occlusion rates. METHODS: Intensive care unit (ICU) patients who required a PICC were randomized to one of three types of dual lumen PICC (open ended non-valved, Groshong valve, PASV valve). PICC occlusions were recorded and managed with a protocol that used urokinase. RESULTS: A total of 102 patients were recruited to the study. The overall risk of occlusion per catheter was 35% (95% CI 26% to 44%). The overall rate of occlusion was 76 occlusions per 1000 catheter days (95% CI 61 to 95). Presence or type of valve did not significantly influence this rate (open-ended non-valved PICC 38% of catheters, 79 occlusions per 1000 catheter days; Groshong 38% of catheters, 60 occlusions per 1000 catheter days; PASV 27% of catheters, 99 occlusions per 1000 catheter days). The dose of urokinase required to treat PICC occlusions did not significantly differ between PICC types. CONCLUSIONS: Valved PICCs do not appear to influence PICC occlusion rates.


Asunto(s)
Obstrucción del Catéter/etiología , Cateterismo Venoso Central/instrumentación , Cateterismo Periférico/instrumentación , Catéteres Venosos Centrales , Trombosis Venosa Profunda de la Extremidad Superior/etiología , Adulto , Anciano , Cateterismo Venoso Central/efectos adversos , Cateterismo Periférico/efectos adversos , Terminación Anticipada de los Ensayos Clínicos , Inglaterra , Diseño de Equipo , Femenino , Fibrinolíticos/uso terapéutico , Humanos , Unidades de Cuidados Intensivos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Terapia Trombolítica/métodos , Resultado del Tratamiento , Trombosis Venosa Profunda de la Extremidad Superior/diagnóstico , Trombosis Venosa Profunda de la Extremidad Superior/tratamiento farmacológico , Activador de Plasminógeno de Tipo Uroquinasa/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA